GR113808 (intraperitoneal injection; 1 mg/kg; 5-7 days starting 24 h after induction of colitis) shows a significant increase in the disease activity index (DAI),which includes evaluation of weight loss, stool consistency, and presence of fecal blood.
Animal Model: |
Mice |
Dosage: |
1 mg/Kg |
Administration: |
Intraperitoneal injection; 1 mg/Kg; 5-7 days starting 24 h after induction of colitis |
Result: |
Blocked protective effects of tegaserod after induction of colitis. |